In addition to 2′-Fucosyllactose, Jennewein Biotechnologie produces other neutral as well as sialylated human milk oligosaccharides (HMOs). On the one hand, we are following the composition and concentration of HMOs in human milk in order to replicate the health benefits provided by natural breast milk. On the other hand, we are considering promising applications for these additional HMOs, particularly their prebiotic effects and their ability to reduce the risk of infection by certain bacterial and viral pathogens. Our goal is to provide commercial quantities of the predominant human milk oligosaccharides at attractive prices and commercial volumes for use as food ingredients.
The additional human milk oligosaccharides produced by Jennewein Biotechnologie are used in preclinical and clinical studies, and for the development of nutritional products. We collaborate closely with well-known food companies and leading academic institutions to test the functional properties and use of our human milk oligosaccharides.
Jennewein Biotechnologie and its local partners are happy to provide more detailed information about our range of HMOs as well as on opportunities to cooperate on request.